FDA Inspection 1298554 — Seattle Reproductive Medicine, PLLC
The FDA completed an inspection of Seattle Reproductive Medicine, PLLC on January 14, 2026 in Kirkland, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 14, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Kirkland, WA (United States)